Iatrogenicity : : Causes and Consequences of Iatrogenesis in Cardiovascular Medicine / / ed. by John B. Kostis, Ibrahim Akin, Martin Borggrefe, Giovanni Campanile, Arshad Jahangir, William J Kostis, Gan-Xin Yan, Ihor B. Gussak.

Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a hu...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter Rutgers University Press Complete eBook-Package 2017
MitwirkendeR:
HerausgeberIn:
TeilnehmendeR:
Place / Publishing House:New Brunswick, NJ : : Rutgers University Press, , [2017]
©2017
Year of Publication:2017
Language:English
Online Access:
Physical Description:1 online resource (448 p.) :; 32 line drawings
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Contents
  • Contributors
  • The Concept of Iatrogenicity
  • PART I. Medical Harm
  • CHAPTER 1. Iatrogenicity: Definition, History, and Modern Context
  • CHAPTER 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions
  • CHAPTER 3. Risk Management: The Medical Center Administration Perspective
  • CHAPTER 4. Iatrogenicity from the Patient's Perspective
  • CHAPTER 5. A Naturopathic Perspective on Iatrogenesis
  • PART II. Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
  • CHAPTER 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes
  • CHAPTER 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
  • CHAPTER 8. Chemotherapy-Induced Cardiomyopathy
  • CHAPTER 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension
  • CHAPTER 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes
  • CHAPTER 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
  • CHAPTER 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
  • CHAPTER 13 Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect
  • CHAPTER 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents
  • CHAPTER 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System
  • CHAPTER 16. Iatrogenicity and Antianginal Drugs
  • CHAPTER 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?
  • CHAPTER 18. Cardiovascular Iatrogenicity in Older Adults
  • PART III. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
  • CHAPTER 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology
  • CHAPTER 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology
  • CHAPTER 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
  • CHAPTER 22. Iatrogenic Aspects of Cardiac Electrophysiology
  • CHAPTER 23. Iatrogenic Aspects in Cardiac Device
  • CHAPTER 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic Modalities
  • PART IV. Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications
  • CHAPTER 25. Trained Athletes
  • CHAPTER 26. Sports Cardiology
  • CHAPTER 27. Dangers of Lifestyle Modification Advice
  • PART V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine
  • CHAPTER 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications
  • CHAPTER 29. Interactions Between Supplements and Medications
  • Index